Metagenomi downgraded by JP Morgan with a new price target

5/2/24 6:29:35 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

JP Morgan downgraded Metagenomi from Overweight to Neutral and set a new price target of $6.00 from $16.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MGX

Date	Price Target	Rating	Analyst
5/7/2024	$10.00	Buy	H.C. Wainwright
5/2/2024	$16.00 → $6.00	Overweight → Neutral	JP Morgan
3/5/2024		Outperform	TD Cowen
3/5/2024	$22.00	Outperform	BMO Capital Markets
3/5/2024	$16.00	Overweight	JP Morgan
3/5/2024	$23.00	Buy	Jefferies
3/5/2024	$21.00	Buy	Chardan Capital Markets
3/5/2024	$25.00	Overweight	Wells Fargo